All Stories

  1. Updates in the Management of EGFR-Mutated Non-small Cell Lung Cancer (NSCLC)
  2. Successful Tarlatamab Rechallenge After Recurrent High-Grade CRS in Chromothripsis-Mediated SCLC
  3. Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies
  4. Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies
  5. Clinically Explainable Prediction of Immunotherapy Response Integrating Radiomics and Clinico-Pathological Information in Non-Small Cell Lung Cancer
  6. Dosing immune-checkpoint inhibitors: Opportunities for the future
  7. SUPE_R Surveillance? PET/CT in Post-Treatment NSCLC and the Imperative of Proof Before Practice
  8. Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Before Chemoradiation in Unresectable Stage III Non–Small Cell Lung Cancer
  9. Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives
  10. Time to rethink platinum choices in the era of immunotherapy in lung cancer
  11. Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers
  12. TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers
  13. Current perspectives of KRAS in non-small cell lung cancer
  14. Plasma cfDNA in Carcinoma of unknown primary: A case series
  15. Data from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  16. Data from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  17. Supplementary Figures from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  18. Supplementary Figures from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  19. Supplementary Tables from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  20. Supplementary Tables from Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  21. Paraganglioma of the Head and Neck: A Review
  22. Application of Value Framework to Phase III Trials of Immune Checkpoint Inhibitors in Esophageal and Gastric Cancer
  23. The contemporary management of cancers of the sinonasal tract in adults
  24. Assessing the risk of thromboembolism in cancer patients receiving immunotherapy
  25. Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans
  26. Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
  27. Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma
  28. Mass Effect Deformation Heterogeneity (MEDH) on Gadolinium-contrast T1-weighted MRI is associated with decreased survival in patients with right cerebral hemisphere Glioblastoma: A feasibility study
  29. Shape Features of the Lesion Habitat to Differentiate Brain Tumor Progression from Pseudoprogression on Routine Multiparametric MRI: A Multisite Study
  30. Radiomics and radiogenomics in lung cancer: A review for the clinician
  31. Prostate shapes on pre-treatment MRI between prostate cancer patients who do and do not undergo biochemical recurrence are different: Preliminary Findings
  32. NIMG-80. SHAPE ATTRIBUTES OF ENHANCING LESION BOUNDARIES CAN DIFFERENTIATE TUMOR RECURRENCE FROM PSEUDO-PROGRESSION ON ROUTINE BRAIN MRI SCANS: PRELIMINARY FINDINGS
  33. Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images
  34. MEDU-48. MRI TEXTURAL FEATURES CAN DIFFERENTIATE PEDIATRIC POSTERIOR FOSSA TUMORS
  35. Seven versus 10 days antibiotic therapy for culture-proven neonatal sepsis: A randomised controlled trial
  36. Co-registration of pre-operative CT with ex vivo surgically excised ground glass nodules to define spatial extent of invasive adenocarcinoma on in vivo imaging: a proof-of-concept study
  37. FRMD4A/RET: A Novel RET Oncogenic Fusion Variant in Non–Small Cell Lung Carcinoma
  38. Field Effect Induced Organ Distension (FOrge) Features Predicting Biochemical Recurrence from Pre-treatment Prostate MRI
  39. Spur cell anemia in Wilson's disease: a rare presentation
  40. Crack cocaine–induced laryngeal injury: a case report
  41. Research letters
  42. Two Cases of NK/T Cell Lymphoma Presenting as Chronic Rhinosinusitis
  43. Burnout and Sleep Quality: A Cross-Sectional Questionnaire-Based Study of Medical and Non-Medical Students in India
  44. Porphyria cutanea tarda in a child with acute lymphoblastic leukemia
  45. Congenital anomaly
  46. Socio-economic profile of patients with community-acquired skin and soft tissue infections in Delhi
  47. Estimation of Gestational Age, Using Neonatal Anthropometry: A Cross-sectional Study in India
  48. Objective, Structured Proforma to Score the Merit of Scientific Presentations
  49. Case Reports
  50. Infective Gangrene in Extremity Trauma—Are We Targeting the Right Organisms?
  51. Congenital tuberculosis: a rare manifestation of a common disease
  52. Oral dextrose for analgesia in neonates during nasogastric tube insertion: A randomised controlled trial
  53. From the editors of a Student journal
  54. Costs of End-of-Life Care
  55. Psychomotor performance of medical students: Effect of 24 hours of sleep deprivation
  56. Leprosy and psoriasis co-existence
  57. Effect of caffeine on information processing: Evidence from stroop task
  58. Quality of life in patients with obsessive compulsive disorder: A longitudinal study from India